Inspire Medical Systems, Inc. INSP
70.50
1.69
2.46%
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 15.1×
Follow INSP
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 17.96% | 18.37% | 19.77% | 6.54% |
+8 more TTM periods Free account |
|
| 15.63% | 15.97% | 16.95% | 5.56% | ||
ROIC |
6.70% | 6.31% | 6.73% | 6.68% | |
Return on Tangible Assets |
21.04% | 22.68% | 24.84% | 7.86% | |
Average Days of Receivables |
41.97 | 41.91 | 47.90 | 44.66 | |
Free Cash Flow per Share |
4.06 | 3.37 | 2.67 | 3.37 | |
Free Cash Flow |
117.09 | 96.71 | 78.48 | 98.82 | |
Capital Expenditures |
(39.98) | (39.82) | (38.50) | (34.87) | |
Piotroski F-Score |
6.00 | 5.00 | 4.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
13.70% | 12.69% | 10.74% | 13.52% | |
Accounts Receivable Turnover |
7.46 | 9.26 | 8.57 | 8.93 | |
Accounts Payable Turnover |
3.11 | 3.67 | 3.54 | 2.83 | |
Inventory Turnover |
0.85 | 0.98 | 1.18 | 1.27 | |
Average Days of Payables |
79.37 | 117.33 | 100.18 | 162.40 | |
Days of Inventory on Hand |
499.17 | 466.07 | 398.06 | 388.67 | |
Tax Rate |
0.95 | 1.05 | 1.21 | (0.14) | |
Research and Development Expense of Revenue |
11.09% | 11.06% | 11.31% | 12.30% | |
Selling, General and Administrative Expense of Revenue |
69.02% | 69.11% | 68.49% | 68.45% | |
Share Based Compensation of Revenue |
13.28% | 14.19% | 14.28% | 14.89% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.16 | 1.04 | 0.80 | 3.00 | |
Depreciation/Fixed assets |
0.15 | 0.14 | 0.11 | 0.09 | |
Capex/Depreciation |
(2.51) | (2.83) | (3.48) | (4.07) | |
Revenue per Share |
31.17 | 31.89 | 31.05 | 30.09 | |
Operating CF per Share |
5.45 | 4.76 | 3.98 | 4.56 | |
Capex per Share |
(1.39) | (1.39) | (1.31) | (1.19) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.04 | |
Net Profit Margin |
15.03% | 14.33% | 15.95% | 5.05% |
Columns are period end dates